Literature DB >> 23885001

Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women.

Timothy Kudinha1, James R Johnson, Scott D Andrew, Fanrong Kong, Peter Anderson, Gwendolyn L Gilbert.   

Abstract

The recent emergence of multidrug-resistant Escherichia coli sequence type 131 (ST131) has coincided with an increase in general antibiotic resistance of E. coli, suggesting that ST131 has a contributing role in resistance. However, there is little information about the contribution of ST131 to different clinical syndromes or the basis for its impressive emergence and epidemic spread. To investigate this, we studied 953 E. coli isolates from women of reproductive age in the central west region of New South Wales, Australia, including 623 urinary isolates from patients with cystitis (cystitis isolates) (n = 322) or pyelonephritis (pyelonephritis isolates) (n = 301) and 330 fecal isolates from healthy controls. The characteristics studied included ST131 clonal group status, resistance to different antibiotics, presence of virulence factor (VF) genes, and biofilm production. As expected, fecal isolates differed significantly from urinary (cystitis and pyelonephritis) isolates in most of the studied characteristics. Antibiotic resistance was significantly more common in ST131 than in non-ST131 isolates. Both antibiotic resistance and ST131 were more common in pyelonephritis than cystitis isolates and least so among fecal isolates. Within each source group, individual VF genes were more prevalent and VF scores were higher for ST131 than for non-ST131 isolates. For ST131 only, the prevalences of most individual VF genes and VF scores were the lowest in the fecal isolates, higher in the cystitis isolates, and highest in the pyelonephritis isolates. Biofilm production was strongly associated with ST131 status and antibiotic resistance. These results clarify the distribution of the ST131 clonal group and its epidemiological associations in our region and suggest that it exhibits both enhanced virulence and increased antibiotic resistance compared with those of other urinary tract infection (UTI) and fecal E. coli isolates from women of reproductive age.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23885001      PMCID: PMC3811657          DOI: 10.1128/JCM.01315-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  43 in total

1.  Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the netherlands.

Authors:  W Goettsch; W van Pelt; N Nagelkerke; M G Hendrix; A G Buiting; P L Petit; L J Sabbe; A J van Griethuysen; A J de Neeling
Journal:  J Antimicrob Chemother       Date:  2000-08       Impact factor: 5.790

2.  Antimicrobial resistance in Escherichia coli causing urinary tract infections in Costa Rica: a clinical dilemma.

Authors:  David N Williams; Mark R Sannes; Alison A Eckhoff; Phillip K Peterson; James R Johnson; Mark R Sannes; Marielos San Román; Nury Mora; Javier Moya
Journal:  Int J Antimicrob Agents       Date:  2003-01       Impact factor: 5.283

Review 3.  Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs.

Authors:  Betsy Foxman; Patricia Brown
Journal:  Infect Dis Clin North Am       Date:  2003-06       Impact factor: 5.982

4.  High prevalence of acquired antimicrobial resistance unrelated to heavy antimicrobial consumption.

Authors:  Alessandro Bartoloni; Filippo Bartalesi; Antonia Mantella; Emanuela Dell'Amico; Mimmo Roselli; Marianne Strohmeyer; Herlan Gamboa Barahona; Virgilio Prieto Barrón; Franco Paradisi; Gian Maria Rossolini
Journal:  J Infect Dis       Date:  2004-03-16       Impact factor: 5.226

5.  Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men.

Authors:  Joaquim Ruiz; Karine Simon; Juan P Horcajada; Maria Velasco; Margarita Barranco; Gloria Roig; Antonio Moreno-Martínez; Jose A Martínez; Teresa Jiménez de Anta; Josep Mensa; Jordi Vila
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

6.  Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001.

Authors:  James R Johnson; Michael A Kuskowski; Abby Gajewski; Daniel F Sahm; James A Karlowsky
Journal:  J Infect Dis       Date:  2004-10-07       Impact factor: 5.226

7.  Genotypic and phenotypic characterization of Escherichia coli isolates from children with urinary tract infection and from healthy carriers.

Authors:  Timothy Kudinha; James R Johnson; Scott D Andrew; Fanrong Kong; Peter Anderson; Gwendolyn L Gilbert
Journal:  Pediatr Infect Dis J       Date:  2013-05       Impact factor: 2.129

8.  Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans.

Authors:  James R Johnson; Michael A Kuskowski; Krista Owens; Abby Gajewski; Patricia L Winokur
Journal:  J Infect Dis       Date:  2003-08-15       Impact factor: 5.226

9.  Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from the Netherlands.

Authors:  James R Johnson; Cindy van der Schee; Michael A Kuskowski; Wil Goessens; Alex van Belkum
Journal:  J Infect Dis       Date:  2002-11-22       Impact factor: 5.226

10.  The homogeneity of the faecal coliform flora of normal school-girls, characterized by serological and biochemical properties.

Authors:  G Lidin-Janson; B Kaijser; K Lincoln; S Olling; H Wedel
Journal:  Med Microbiol Immunol       Date:  1978       Impact factor: 3.402

View more
  27 in total

Review 1.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131.

Authors:  James R Johnson; Olivier Clermont; Brian Johnston; Connie Clabots; Veronika Tchesnokova; Evgeni Sokurenko; Adam F Junka; Beata Maczynska; Erick Denamur
Journal:  J Clin Microbiol       Date:  2014-02-05       Impact factor: 5.948

3.  Large Fecal Reservoir of Escherichia coli Sequence Type 131-H30 Subclone Strains That Are Shared Within Households and Resemble Clinical ST131-H30 Isolates.

Authors:  Muhanad Mohamed; Connie Clabots; Stephen B Porter; Tricia Bender; Paul Thuras; James R Johnson
Journal:  J Infect Dis       Date:  2020-04-27       Impact factor: 5.226

Review 4.  A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131.

Authors:  Ritu Banerjee; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

Review 5.  The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.

Authors:  Amy J Mathers; Gisele Peirano; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

6.  Rapid Emergence, Subsidence, and Molecular Detection of Escherichia coli Sequence Type 1193-fimH64, a New Disseminated Multidrug-Resistant Commensal and Extraintestinal Pathogen.

Authors:  James R Johnson; Brian D Johnston; Stephen B Porter; Connie Clabots; Tricia L Bender; Paul Thuras; Darren J Trott; Rowland Cobbold; Joanne Mollinger; Patricia Ferrieri; Sarah Drawz; Ritu Banerjee
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

Review 7.  Urinary Tract Infection: Pathogenesis and Outlook.

Authors:  Lisa K McLellan; David A Hunstad
Journal:  Trends Mol Med       Date:  2016-09-28       Impact factor: 11.951

8.  Phylogenetic Backgrounds and Virulence-Associated Traits of Escherichia coli Isolates from Surface Waters and Diverse Animals in Minnesota and Wisconsin.

Authors:  James R Johnson; Brian D Johnston; Parissa Delavari; Paul Thuras; Connie Clabots; Michael J Sadowsky
Journal:  Appl Environ Microbiol       Date:  2017-12-01       Impact factor: 4.792

9.  Long-Term Care Facilities Are Reservoirs for Antimicrobial-Resistant Sequence Type 131 Escherichia coli.

Authors:  Mary J Burgess; James R Johnson; Stephen B Porter; Brian Johnston; Connie Clabots; Brian D Lahr; James R Uhl; Ritu Banerjee
Journal:  Open Forum Infect Dis       Date:  2015-02-17       Impact factor: 3.835

10.  Genomic analysis of trimethoprim-resistant extraintestinal pathogenic Escherichia coli and recurrent urinary tract infections.

Authors:  Dmitriy Li; Cameron J Reid; Timothy Kudinha; Veronica M Jarocki; Steven P Djordjevic
Journal:  Microb Genom       Date:  2020-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.